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Abstract
Objective To explore perspectives of physicians and pharmacists on diabetes
service delivery within community pharmacies in Indonesia.
Methods In depth interviews were conducted with 10 physicians and 10 commu-
nity pharmacists in Surabaya, Indonesia, using a semi-structured interview guide.
Nvivo version 9 was used to facilitate thematic content analysis to identify barriers/
facilitators for community pharmacists to provide diabetes services.
Key findings The identified themes indicating barriers/facilitators for diabetes
service delivery within Indonesian community pharmacies included: (1) pharmacist
factors − i.e. positive views (facilitator) and perceived lack of competence (barrier);
(2) pharmacist–physician relationships – i.e. physicians’ lack of support and acces-
sibility (barriers); (3) pharmacist–patient relationships – i.e. perceived patients’ lack
of support and accessibility (barriers); (4) pharmacy environment − i.e. business
orientation (barrier), lack of staff and poor pharmacist availability (barriers), and
availability of supporting resources, such as counselling areas/rooms, procedures/
protocols and IT systems for labelling and patient records (facilitators); and (5)
external environment − i.e. a health system to support pharmacist roles, remunera-
tion, marketing and professional assistance (facilitators).
Conclusion Issues related to the pharmacist–physician–patient relationships, phar-
macy environment and external environment need to be addressed before Indo-
nesian community pharmacists can provide additional pharmacy services for type 2
diabetes patients. Collaboration between the Government, Ikatan Apoteker Indo-
nesia (Indonesian Pharmacists Association) and Ikatan Dokter Indonesia (Indo-
nesian Medical Association) is required to improve the pharmacy professional
environment and facilities.
Introduction
Diabetes is emerging as a chronic disease in developing coun-
tries. Indonesia is a major developing country with a popula-
tion of 237.6 million.[1] It was estimated that in 2013, 8.5
million people in Indonesia were living with diabetes, and is
expected to increase to 14.1 million by 2035.[2] In developing
countries such as Indonesia, chronic diseases are currently
managed in hospital outpatient or clinic settings.[3,4] The
burgeoning chronic disease burden provides an opportunity
for Indonesian community pharmacists to extend their
services.
Studies worldwide have explored barriers/facilitators of
pharmacists to move towards a more patient-orientated
model of practice.[5–16] The majority of the studies were con-
ducted in developed countries using questionnaires.Of those,
two studies reviewed barriers/facilitators that were specific to
diabetes services. Plake et al. in the USA reported that remu-
neration, workload and available time were perceived as the
most limiting barriers.[12] Berbatis et al. in Australia reported
facilitators for diabetes service delivery included pharmacies
with higher turnover and pharmacists with higher training
hours,while the identifiedbarrierswere lackof confidenceand
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As developed countries often have a different context,
translating those findings to pharmacy practice in developing
countries such as Indonesia is inappropriate. In the current
Indonesian health system in which physicians are the primary
care providers and the concept of shared patient care is new, it
is important to explore physicians’ and pharmacists’ perspec-
tives regarding the potential integration of pharmacists in
diabetes care. Two qualitative studies conducted in Indonesia
have expressed concerns with pharmacist competencies and
availability/presence in the pharmacy to provide patient
care.[7,15] This present study aimed to explore perspectives of
physicians and pharmacists on diabetes service delivery
within community pharmacies in Indonesia.
Methods
This study was approved by the Human Research Ethics
Committee of Curtin University (PH-09-11) and Ikatan
Apoteker Indonesia (IAI; Indonesian Pharmacists Associa-
tion) (001/SK/BPD-IAI/SURABAYA/2010).
Setting and participant recruitment
The study was conducted in Surabaya, the second largest city
in Indonesia, with approximately 3.1 million inhabitants.[17]
As factors influencing service delivery are subjective, a quali-
tative exploratory design was chosen for this study to under-
stand individual viewpoints.[18] Data were collected from
in-depth interviews of physicians and community pharma-
cists in Surabaya, Indonesia.
Community pharmacists were recruited from respondents
involved in a previous pharmacist questionnaire-based
survey conducted by the first author (YW).[19] A purposive
sample of 10 pharmacists was initially selected based on the
characteristics of the pharmacy premises: attachment to a
medical clinic, number of patients seeking antidiabetic medi-
cations, availability of a counselling room and levels of phar-
macist availability. Pharmacist availability was calculated as a
ratio of total reported pharmacist working hours per week to
total pharmacy opening hours per week. A ratio of one or
more would indicate that there was always a pharmacist avail-
able during pharmacy opening hours. While the intention
was to recruit physicians treating type 2 diabetes patients, this
task was difficult as there was no available sampling frame of
the specialities of physicians at medical clinics in Surabaya.
Therefore, the community pharmacists involved in the inter-
views were asked to provide information on physicians
who frequently prescribed antidiabetic medications. Ten
physicians were purposively selected based on their level of
practice (general practitioner (GP), specialist and endocri-
nologist). Pharmacists and physicians were contacted by YW
either by telephone or in person to discuss the nature of the
study; if they agreed to participate, an appointment for the
interview was made. The initial interview target was 10 par-
ticipants of each group, which was reviewed iteratively to
ensure saturation was reached.
Data collection
In-depth face-to-face interviews were conducted in Bahasa
Indonesia by YW (an academic pharmacist in Indonesia
whose first language is Bahasa Indonesia) between May and
December 2012, either within the participants’ premises
or in YW’s office. Written informed consent was obtained.
The interviews were aided by a semi-structured interview
guide which was developed in conjunction with all authors
and was field tested. The guide explored three areas: (1)
current practice, (2) future roles, and (3) barriers/
facilitators for the provision of diabetes services (Tables 1
and 2); this paper places more emphasis on the barriers/
facilitators element of the interview guide. Probing ques-
tions were asked when necessary to expand participants’
responses. A separate form was used to gather demographic
details of participants and their premises. The interviews
took 30–60 min and were audio-recorded. All participants
were reimbursed for their time.
Data analysis
The audio-recorded interviews (Bahasa Indonesia) were
transcribed verbatim. Thematic content analysis was used to
identify barriers/facilitators to the service.[20] The transcripts
were coded by YW; then, the open codes were categorised and
themes extracted. Examples of comments were provided to
illustrate context to the themes. This involved translating the
comments into English. This approach enabled the analysis to
stay in the source language as long and as much as possible,
thus avoiding potential limitations when analysing in another
language than the source language.[21] The themes together
with the illustrative comments were reviewed by the other
two authors (Professors of Pharmacy) to ensure the common
sense of the interpretation. Themes and comments in Bahasa
Indonesia were sent to the participants for feedback. This was
used as a means of ‘member-checking’ to ensure credibility of
the data.[22] The data management used the NVivo database
(QSR NVivo, version 9.0, QSR International, Melbourne –
Australia).
Results
Of those contacted for interviews, one pharmacist and one
physician said they were too busy to participate and were
replaced. Before the completion of the planned 20 interviews
(i.e. after the eighth pharmacist interview and the eighth phy-
sician interview), data saturation was achieved (i.e. no new
themes emerged); thus, further recruitment beyond 10 phar-
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Table 1 Interview guide – community pharmacist
Opening
The marked increase of type 2 diabetes patients in Indonesia will place pressure on health care workers to ensure optimal diabetes management. In
this situation, there is a need to make better use of health care resources in the community, including community pharmacies.
1. When a patient with type 2 diabetes visits your pharmacy, please describe services provided.
Probe/challenge them on each point in the generic model of care, starting with:
• Dispensing
• Education/counseling
• Monitoring – include monitoring compliance, monitoring treatment outcomes and adverse effects (may need to perform clinical tests, check
laboratory data and/or interview the patient regarding his/her clinical problems)
• Based on the monitoring – involve in adjusting treatment plan, adjusting patient education or referring patients to other health care professionals
2. What do you think community pharmacists SHOULD do for type 2 diabetes patients?




• Based on the monitoring – involve in adjusting treatment plan, adjusting patient education or referring patients to other health care professionals
(If they mention services beyond dispensing)
Probe: Why do you think this (service) is important?
(If they mention no services should be provided – except for dispensing medications)
Probe: What things made you think that community pharmacists should only do dispensing?
(If the services mentioned have not done – compare point 2 to point 1)
Probe: Barriers – what things made it difficult for you to provide (the service)?
In closing
Our project is about the role of community pharmacists with respect to diabetes care. Does anything else come to mind that I haven’t asked you
about?
Thank you for your participation.
Table 2 Interview guide – physician
Opening
The marked increase of type 2 diabetes patients in Indonesia will place pressure on health care workers to ensure optimal diabetes management. In
this situation, there is a need to make better use of health care resources in the community. In other countries such as Australia, community
pharmacists have a more active role within diabetes team, such as: repeat medications (i.e. physicians prescribe medications that allow patients to
refill their medication for certain times where pharmacists ensure their diabetes control), patient education/counseling and monitoring (e.g. blood
glucose level, blood pressure, weight).
1. When a patient with type 2 diabetes visits your clinic, please describe a typical consultation/assessment provided.
2. What would you like community pharmacists to do in helping your type 2 diabetes patients?
Probe/challenge them on each point in the generic model of care, starting with:
• Dispensing (how about repeat medications?)
• Education/counseling – e.g. medications, lifestyle
Then:
• Monitoring – e.g. involve in monitoring compliance, monitoring treatment outcomes and adverse effects (e.g. perform clinical tests, check
laboratory data and/or interview the patient regarding his/her clinical problems)
• Based on the monitoring – e.g. involve in adjusting treatment plan, adjusting patient education or referring patients to other health care
professionals
(If they mention services beyond dispensing)
Probe: Why do you think this (service) is important to be provided in the pharmacy?
(If they mention no services should be provided – except for dispensing medications)
Probe: What things made you think that community pharmacists should only do dispensing?
(We previously did surveys among patients and pharmacists, and we found areas other than dispensing that pharmacists could be involved, such as
monitoring and counseling)
Probe: What do you think about that?
In closing
Our project is about the role of community pharmacists with respect to diabetes care. Does anything else come to mind that I haven’t asked you
about?
Thank you for your participation.
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macists and 10 physicians was considered unnecessary. The
characteristics of the participants and their premises are pre-
sented at Table 3. The following themes and categories of
responses emerged from the analysis of the interviews
(Table 4).
Theme 1: pharmacist factors
Attitude
Although all pharmacists believed that they should extend
their services beyond basic dispensing, this was not sup-
ported by the majority of physicians.
As a pharmacist, we should be responsible for preparing,
dispensing and providing patient counselling. That’s the
standard. (Pharmacist 4)
In my opinion, pharmacists should not provide anything
other than what physicians have prescribed. If they find it
unclear, they can check with the physician. (Physician 6)
Competence
Some of the pharmacists and physicians expressed concerns
regarding pharmacists’ competence to provide direct patient
care.
To be honest, I do not have the courage to do it (patient
care) on my own . . . I am not that competent. I am afraid
to fail it. (Pharmacist 3)
As I said, pharmacists have a lack of clinical knowledge –
they are still product-minded – as the result of their edu-
cation curriculum. (Physician 3)
Theme 2: pharmacist–physician relationships
Physicians’ attitude
The majority of physicians and pharmacists expressed con-
cerns with the involvement of pharmacists in patient care
since physicians generally considered clinical activity as their
role
In terms of developing a treatment plan with doctors, it
will be too far . . . As we can see . . . even in the inpatient
setting, it is hard for the doctors to accept recommenda-
tions from the clinical pharmacists. (Doctor 1)
While we are trying to help . . . they have accused us of
encroaching on their authority. (Pharmacist 6)
These physicians’ attitudes were influenced by their con-
cerns with pharmacists’ clinical knowledge (Theme 1b) and
by their perceptions around the pharmacy business role;
as Physician 1 illustrated: ‘The pharmacist can be just an
employee at the pharmacy . . . if the owner is more business-
oriented, they will just need the pharmacist’s name to be put as a
manager (and do not care for the pharmacists’ professional
roles)’.
Physicians’ accessibility
While providing patient care requires an effective collabora-
tion with physicians, some pharmacists and physicians
expressed concerns about access to physicians due to physi-
cians’ workload.
Table 3 Characteristics of the participants and their premises




Age, years (range) 26–76
Position, n




Diabetes training, hours 0– >20
Pharmacy characteristics
Ownership, n




Within medical clinic 5
Not within medical clinic 5
Counselling room/area, n 5
Diabetes patients per month, n (range) 70–250
Pharmacist availability*, ratio (range) 0.3–2.1




Age, years (range) 41–82
Level, n
General practitioner (GP) 3




With on-site pharmacy 8
Without on-site pharmacy 2
Diabetes patients per month, n (range) 50–300
*Ratio of total pharmacist working hours per total pharmacy opening
hours.
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When we identified problems, contacting physicians was
a challenge . . . particularly for those with lots of patients.
(Pharmacist 2)
. . . in the primary care setting where the load is high and
we should work fast, time for communication is limited.
(Physician 1)
Thus, the importance of relationship building was
discussed by some pharmacists and physicians to improve
support from physicians. Two of the physicians had
gained trust in pharmacists after working together with
them over some time; as Physician 2 said: ‘In my opinion,
what the pharmacist “X” has been doing is excellent. As I
have limited ability, limited time . . . I guess we should appre-
ciate others who are willing to provide more care to the
patients’.
Theme 3: pharmacist–patient relationships
Patients’ attitude
A majority of pharmacists stated the importance of patient
demand in reinforcing practice change; as Pharmacist 8 illus-
trated: ‘I did PMRs (Patient Medication Records) before, but
not anymore, as there is no demand.’ It was perceived the
current lack of demand was because patients had low expec-







Attitude - Pharmacists’ positive
views in providing
patient care
Ph:1, 2,3, 4, 5, 6, 7, 8, 9, 10
P: 1, 3, 4, 6, 9, 10
Competence - Concerns for pharmacists’
competence to provide patient care









- Lack of support from physicians –




Ph: 2,3, 5, 6, 7, 10
P: 1, 3, 4, 6, 9, 10
Physician’s
accessibility
- Low accessibility to physicians –






Patient’s attitude - Lack of demand from patients –
lack of awareness, retailer image
Ph: 3, 5, 6, 8, 9, 10
Patient’s accessibility - Low accessibility to patients – not
coming in person, having no time,
not coming on a regular basis
Ph: 1, 2, 3, 4, 5, 6, 9
4. Pharmacy
environment
Practice orientation - Professional orientation Ph: 1, 8, 10
- Business orientation Ph: 6
Staff resources - Lack of staff Ph: 5, 3, 10
- Task delegation Ph: 6, 7
Pharmacist
availability/time
- Lack of pharmacist availability/time Ph: 1, 2, 5, 6, 7, 9
P: 1, 5, 7, 8
Operational - Counselling areas/rooms Ph: 1, 7
- Difficulty to maintain PMRs Ph: 1, 2, 6, 7, 8
- Poor labelling Ph: 1, 7, 8
P : 8, 10
- Protocols/procedures Ph: 1, 2, 4, 6
5. External
environment
Organisation of roles - A health system to
support delegation of
roles to pharmacists
- Lack of a health system to support
pharmacist roles (physician
dominance)
Ph: 3, 5, 6
P : 1, 2, 4, 6
Financing - Remuneration system Ph: 6





- Training for pharmacists Ph: 5, 8, 9, 10
- Mentors Ph: 3
P, physician; Ph, pharmacist; PMR, patient medication record.
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tations towards a pharmacist. Perceptions around pharma-
cists as retailers as well as healthcare providers might also
create uncertainty regarding the pharmacists’ roles in patient
care; as Pharmacist 3 said: ‘When I told them not to purchase
only two or nine tablets (explaining that otherwise the problem
would recur) . . . they did not comply . . . probably they thought
that I just care to sell my products.’ Physicians also indicated
concerns regarding the business role of pharmacy (Theme
2a).
Patients’ accessibility
Some pharmacists reported that the provision of patient care
was often hampered by difficulty in accessing patients, such as
them not coming in person, having no time or not coming on
a regular basis. Moreover, pharmacists expressed concerns
that patients could switch from one pharmacy to another on
successive visits, making accuracy of PMRs and service conti-
nuity difficult. As Pharmacist 4 stated: ‘. . . in Indonesia,
(most) patients are not covered by insurance plans. They could
choose whichever pharmacy they like’.
Hence, it was considered important to develop a profes-
sional relationship between the pharmacist and the patient to
improve support from patients. Two pharmacists reported
the use of simple questions about patient medications at the
first meeting, to help the patients to recognise their need.
They suggested that once the patients valued the service, they
would be willing to access the service; as Pharmacist 1 illus-
trated: ‘This patient was first counselled about the use of her
medication few days ago . . . now she asks if she can access the
service in the future’.
Theme 4: pharmacy environment
Practice orientation
Some pharmacists reported that practice orientation of the
pharmacy owners has influenced the provision of patient
care. If owners (especially non-pharmacist owners) are
unaware of the professional service, or it is not a priority, the
service will be vulnerable to other business pressures; as Phar-
macist 6 said: ‘What they (pharmacy owners) have developed
really well is accounting . . . financial reports etc’. In contrast,
professionally active owners shared motivation to shift
towards a more professional role and did not necessarily
focus on maximising profit; as Pharmacist 1 (the pharmacy
owner/manager) commented: ‘I told the pharmacy staff to
refer patients with chronic diseases to the pharmacist . . . so that
they can be counselled properly’.
Staff resources
Some pharmacists wanted adequate pharmacy staff to release
pharmacists’ time to do patient care; as Pharmacist 5 stated:
‘If I have enough staff – a lot of pharmacy assistants – I will not
need to dispense medications – preparing labels and such things
– that now causes me to have no time for patient care’. More-
over, some pharmacists noted the importance of teamwork
and task delegation in the pharmacy to support their profes-
sional development; as Pharmacist 7 illustrated: ‘. . . from
accepting prescriptions to dispensing has been handled by the
pharmacy assistants . . . the pharmacists should be at the front
(counter) directly facing the customers’.
Pharmacist availability/time
To provide patient care, about half of the physicians and
pharmacists emphasised that a pharmacist needs to be avail-
able at the pharmacy during opening hours.
I have tried to provide this kind of service (patient care),
but I was not always available in the pharmacy/ I also
have another job at another place. (Pharmacist 2)
. . . the problem is that pharmacists are not always avail-
able at pharmacies. (Physician 5)
Operational
Half of the pharmacies have developed PMRs; however,
obtaining complete data and utilising PMRs on a regular
basis were reported to be a challenge (e.g. problems with PMR
retrieval (hardcopy PMRs), lack of pharmacists’ time and
lack of patient access). In addition to issues with PMRs, there
was lack of written information and typical pharmacy labels
included limited information; as Physician 8 stated: ‘. . . they
only put on how many times patients should take the medica-
tions – before or after food – but there is no drug name and
strength. Hence, it would cause a mess when patients acciden-
tally put the medication in the wrong medication bag’.
Some pharmacists mentioned that procedures and proto-
cols could be important to ensure consistency and quality of
service. The need for a consultation area/room was discussed
by a few pharmacists for personal/private issues.
Theme 5: external environment
Organisation of roles
Some pharmacists and physicians perceived that the current
healthcare system has not diversified (physician dominance).
Thus, it was considered to clearly define roles among physi-
cians and pharmacists:
. . . the IDI (Ikatan Dokter Indonesia – Indonesian
Medical Association) and the IAI – with the Government
as the facilitator – should have an agreement about each
International Journal of Pharmacy Practice 2016, 24, pp. 180--188 © 201 Royal Pharmaceutical Society
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other’s roles in order to provide optimal care for diabetics,
e.g. repeat dispensing. (Pharmacist 6)
I am hoping that health professionals share the same
understanding of diabetes care . . . Basically, I hope that
patients will not be afraid of taking insulin, medications,
regular control, regular SMBG, when necessary. As for
this, I cannot work alone . . . (Physician 2)
Funding
While currently pharmacies have only charged a low dispens-
ing fee, Pharmacist 6 believed that it was important for phar-
macists to demonstrate their value; thus, they should be
reimbursed for further services: ‘Especially with the Jaminan
Kesehatan Nasional – JKN (National Health Insurance)
coming up . . . this will clearly define physicians’ and pharma-
cists’ roles. In this case, how can’t pharmacists get remuneration
if we already provide services?’
Marketing
For a service to be successful, Pharmacist 8 considered the
importance of a nationwide promotional activity to raise
patient awareness and to help in creating demand: ‘. . . for
example, raising community awareness to put demand on phar-
macies to do this and that. But this should be done at the
national level (structural levels of the IAI)’.
Assistance (profession wide)
Due to the perceived lack of competence to provide patient
care (Theme 1b), some of the pharmacists emphasised the
importance of training from the IAI and educational institu-
tions; as Pharmacist 9 stated: ‘. . . there should be training for
pharmacists . . . to update our knowledge . . . to help us provid-
ing care for the patients’. In addition to training, Pharmacist 3
suggested mentors/advisors to assist during the implementa-
tion of the service: ‘. . . If only I could collaborate with the edu-
cational institution “X” (for example), I am willing to do it
(patient care) . . . Doing it without help is hard for me’.
Discussion
This study has identified, based on pharmacist and physician
perspectives, factors affecting diabetes service delivery within
Indonesiancommunitypharmacies.Someviewsheldbyphar-
macists were a barrier to move towards more patient-centred
practice, and many of the physicians interviewed oppose an
expanded clinical role for community pharmacists. The
current pharmacy and external environment issues are ham-
pering moves towards more advanced practice. The lack of
proper labelling systems, PMR systems and pharmacist avail-
ability in pharmacies are three prime areas that need to be
addressed before these services can be introduced. These
current perceptions may be influenced by very low pharmacist
salaries related to very low dispensing fees where the addition
of any further services would be perceived as either not remu-
nerated or poorly remunerated. The status quo supports the
current business-orientated model. The implementation of
JKN by the Indonesian Government provides an opportunity
to encourage pharmacy practice change, and where appropri-
ate, remuneration should be established for agreed services.
There are some limitations to this study. As qualitative data
are a product of views, experiences and perceptions of
respondents, it can be biased if respondents are not sharing
their true responses.[18] In this case, the current lack of
engagement of community pharmacists in diabetes care may
mitigate some of this potential bias as respondents had no
experience with the service examined. In addition, the results
of this study were provided to interviewees to ensure accuracy
(‘member-checking’).[22] This study used a small sample size,
but it included a range of pharmacists and physicians. No new
themes emerged after the eighth interview for each group
(data saturation), suggesting that all possible issues had been
covered.[18,23]
The consolidated criteria for reporting qualitative studies
(COREQ) 32-item checklist is provided in Table S1.
While pharmacists generally indicated that they should
extend their roles, they perceived a range of barriers. There
were concerns with pharmacist competency in providing
direct patient care. In Indonesia, to become a qualified phar-
macist, it requires completion of the pharmacy undergradu-
ate course of 4-year duration (Bachelor of Pharmacy) which
is followed by 1 year of preregistration training. However, it
should be noted that pharmacotherapy subjects (as a basis for
providing patient care) were not incorporated in the national
pharmacy curricula until 2008.[24,25] Thus, a wide variation of
pharmacotherapy knowledge is expected, particularly among
earlier graduates. The limited pharmacotherapy knowledge
among Indonesian community pharmacists was also
reported in a previous study.[7] With the changes in pharmacy
curricula, it is to be expected that all new pharmacists will
receive general diabetes training as part of their undergradu-
ate programme. While there are currently a variety of oppor-
tunistic continuing professional development courses (some
of which include diabetes as a topic), the IAI should consider
organising formal general diabetes training to help the earlier
graduates; diabetes-specific training and an accreditation
system can be developed for those seeking specialisation.
This study also indicated a perceived lack of support from
physicians and patients. Thus, the IAI should consider liaising
with physician organisations to discuss interactions/
relationships between physicians and community pharma-
cists in providing patient care. While working with
physicians, pharmacists need to demonstrate their value over
time to patient outcomes, allowing continued development
of their professional role. It was suggested that physicians’
acceptance of pharmacists’ clinical role was related to the
level of exposure physicians had had to those services,[26]
© 201 Royal Pharmaceutical Society International Journal of Pharmacy Practice 2016, 24, pp. 180--188
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which is consistent with statements from physician interviews
in this study.
The pharmacist–physician–patient relationship to develop
pharmacist professional roles can be influenced by both the
pharmacy and external environments. It is a government
requirement that prescription medications are issued by
pharmacists.[27,28] However, this study indicated an issue with
pharmacist availability in the pharmacies. This was also
reported in two studies undertaken in Jakarta, Indonesia,
where approximately 70% of pharmacists worked in commu-
nity pharmacies as their side jobs.[29,30] Moreover, this study
has indicated that Indonesian regulations/policies have not
yet developed a diverse healthcare system (due to physician
dominance), thus further limiting pharmacist roles.
The implementation of JKN in 2014 presents an opportu-
nity to improve the utilisation of community pharmacies
(more customers/prescriptions). Under the scheme, the gov-
ernment and IAI should consider establishing a formal agree-
ment regarding basic services that should be available in the
pharmacies; advanced services can be proposed once pilot
studies can provide evidence of their benefits. While the
current payment under JKN includes a very low prescription
fee,[31] the IAI should negotiate with the Government to
ensure that pharmacists receive adequate remuneration for
the provision of agreed basic services to create a stable envi-
ronment for community pharmacy enabling it to remain
viable. In turn, the JKN can be used to reinforce the require-
ment for community pharmacies to maintain pharmacist
availability to be considered as eligible service providers, thus
improving the quality of pharmacy services.
This study identified a need for PMRs and appropriate
labelling. The IAI should consider developing specific stand-
ards and IT systems for dispensing to assist with labelling
quality. The use of IT systems would also improve access to
PMRs which is fundamental to provide direct patient care.
While the Indonesian standard allows the use of pharmacy
assistants to assist in the dispensary,[28] and thus releasing
pharmacists’ time to do patient care, issues related to the
supply and roles of pharmacy assistants warrant further
considerations.
Conclusion
Issues related to the pharmacist–physician–patient relation-
ships, pharmacy environment and external environment
need to be addressed before Indonesian community pharma-
cists can provide pharmacy services for type 2 diabetes
patients. The Government and IAI should prioritise their
support in improving the pharmacy professional environ-
ment and facilities, particularly pharmacist availability
during opening hours, and implementation of IT systems for
labelling and PMRs. An appropriate remuneration system
should also be established to create a stable environment for
community pharmacies to develop new services. Once these
are established, a close liaison with physicians and their gov-
erning bodies is essential to create more formal integration of
community pharmacists within the health system.
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